- Open Access
Identification and management of alcohol use and illicit substance use in outpatient psychiatric clinics in Sweden: a national survey of clinic directors and staff
Addiction Science & Clinical Practicevolume 14, Article number: 10 (2019)
Swedish national guidelines recommend that all health care settings systematically screen patients for alcohol use and illicit substance use. When hazardous use is identified, it should immediately be addressed, preferably through brief interventions (BI). It is well known that the prevalence of alcohol use and illicit substance use among psychiatric patients is high, but it is not known to what extent screening and BI are routinely carried out in such clinics.
Two online surveys investigating the use of screening and BI for alcohol and illicit substances were constructed; one for psychiatric outpatient clinic directors and one for staff at these clinics. The main analyses were calculated as simple frequencies. In secondary analyses, we investigated the associations between substance abuse training, type of clinic and screening/BI delivery. For these analyses, the Chi square test was used.
Most clinic directors reported that they have guidelines to screen for alcohol (93.1%) and illicit substance use (78.9%) at initial assessment. Fifty percent reported having guidelines for delivering BI when identifying hazardous alcohol use (35.9% for hazardous illicit substance use). Among staff, 66.6% reported always screening for alcohol use and 57.8% reported always screening for illicit substance use at initial assessment. Further, 36.7% reported that they usually deliver BI when identifying hazardous alcohol use (35.7% for hazardous illicit substance use). Secondary analyses indicated that staff with substance abuse training were significantly more likely to screen for alcohol use than staff without such training. Further, staff at psychosis clinics were significantly less likely to screen for both alcohol and substance use than staff at both general and specialist psychiatric clinics.
Most clinic directors reported having clear guidelines for staff to screen for alcohol use and illicit substance use, but fewer staff members than expected indicated that these guidelines were adhered to. Providing training about substance use disorders for staff may increase use of screening for alcohol use, and psychosis clinics may need to improve their screening routines.
It is well known from epidemiological studies that people with a psychiatric disorder frequently have a concurrent substance abuse or dependence concerning either alcohol or illicit substances [1,2,3]. Prevalence of substance abuse or dependence among persons in the general population with anxiety or depression is estimated to be 25–30%, with markedly higher levels among those with more severe psychiatric disorders such as schizophrenia . The prevalence is believed to be just as high among patients in psychiatric clinics [4,5,6,7]. Individuals with concurrent psychiatric disorder and substance use problems have a worse treatment prognosis  and an increased risk of later relapse in their psychiatric disorder . Hazardous alcohol use, a drinking pattern not deemed to be a fully developed alcohol abuse or dependence but with potential to lead to adverse consequences, is also problematic in a psychiatric setting. Excessive drinking commonly interferes with psychosocial functioning and raises the risk of subsequent escalation of alcohol problems. In fact, even moderate alcohol intake has a negative impact on clinical course and response to treatment [10, 11], and may interact negatively with common psychiatric medications such as fluoxetine  and benzodiazepines . Reduced hazardous drinking among psychiatric patients has been associated with more rapid symptom improvement in anxiety and depression . Hazardous illicit substance use is not an equally established concept, but it is not controversial to suggest that sporadic use of illicit substances also has negative implications for treatment and recovery from psychiatric disorders.
The importance of detecting both hazardous alcohol use and abuse or dependence among patients in health care settings outside specialized addiction care was established by the World Health Organization with the development of the Alcohol Use Disorders Identification Test (AUDIT), a questionnaire developed specifically to facilitate identification of alcohol problems within primary care . This opportunistic approach to identifying hazardous alcohol use as well as abuse and dependence has subsequently been incorporated into a host of national guidelines such as those issued by the National Institute for Health and Excellence (NICE) in the UK , the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in the United States  and the National Board of Health and Welfare in Sweden . These guidelines propose that health care staff should routinely carry out alcohol screening, preferably with a validated questionnaire such as the AUDIT. When alcohol abuse or dependence is identified, the patient is to be offered referral to appropriate treatment, and when hazardous use of alcohol is identified, this should be addressed immediately within the current health service with structured feedback, preferably by means of a brief intervention (BI). BI is a single-session treatment aimed at helping hazardous drinkers moderate their drinking by providing screening, feedback and brief advice regarding their alcohol consumption. BI has been shown to have small but stable effects in the primary care setting  and in the emergency department setting . Although research on BI in the psychiatric setting is scarce, a few randomized trials have demonstrated that, although efficacy in terms of effects on alcohol consumption is not yet clear, BI is at least feasible and safe to use in this population [20,21,22,23]. In Sweden, some progress has been made in evaluating the implementation of national guidelines for substance abuse and dependence care through quality indicators from the National Patient Registry and the National Quality Registry for Dependency (SBR), but so far no systematic information on screening and BI within psychiatry is available . The importance of detecting illicit substance use has not been placed on the wider healthcare agenda to the same degree as alcohol, but the Drug Use Disorders Identification Test (DUDIT) [25, 26], a parallel instrument to the AUDIT, is nationally recommended by the National Board of Health and Welfare in Sweden for identifying illicit substance use in a variety of health care settings as well as within specialized addiction care . In the UK, the 2011 NICE guidelines on coexisting severe mental illness (psychosis) and substance misuse recommend assessment and management of illicit substance use in wider healthcare settings, specifically stipulating that individuals seeking help within psychiatry should not be excluded due to illicit substance use . In the US, the current focus lies more on ensuring a continuum of care for individuals with illicit substance use , with limited research published on identifying and managing illicit substance use within psychiatry . Regarding the efficacy of BI for illicit substance use, the evidence is unclear. Few studies have been conducted on BI for illicit substance use, and a minority of these have been conducted in clinical settings. Two large randomized trials have been conducted in a primary care population: one of these identified a reduced drug use effect following BI , while another did not . Recent pooled evidence suggests that interventions delivered via the internet could yield small, but significant overall effects beyond control conditions including BI . To our knowledge, no studies have investigated BI for illicit substance use in the context of psychiatry.
Given the high levels of comorbidity and negative implications of both hazardous use and substance abuse/dependence for treatment outcomes, it would seem essential for any psychiatric clinic to have an effective strategy in place to detect and assess these problems among patients. This could be achieved by routinely screening all patients for alcohol and illicit substance use at initial assessment. Such a strategy could identify many patients early on, facilitating collaboration or referral to appropriate substance use treatment. Even better, it could also identify patients with these problems early enough to allow clinicians to offer on-site treatment such as BI or other suitable measures to address and reduce substance use. However, we have found no existing research on the extent to which screening for alcohol and illicit substance use is conducted in psychiatric outpatient clinics, nor to what extent patients with hazardous use of alcohol or illicit substances are offered BI.
The purpose of this study was to investigate current national practices for identifying and managing hazardous substance use and diagnosed substance abuse/dependence (both alcohol and illicit substances) among patients in psychiatric outpatient clinics in Sweden. Specific research questions were:
To what extent do psychiatric outpatient clinics in Sweden have specific guidelines for staff to a) screen for alcohol use and illicit substance use during initial assessment and b) use brief intervention when appropriate?
To what extent do staff in psychiatric outpatient clinics in Sweden a) screen for alcohol use and illicit substance use during initial assessment and b) use brief intervention when appropriate?
Design, participants and setting
The study consisted of two separate cross-sectional online surveys, one for directors at outpatient psychiatric clinics and the second for staff with patient contact at these clinics. Ethical review resulted in a consultative statement by the Regional Ethics Review Board in Stockholm, Sweden, stating that no ethical review was deemed necessary (2012/1695-31/5).
The psychiatry coordinators for each of the 21 counties in Sweden were contacted with a request to provide e-mail addresses for all directors of outpatient psychiatry clinics in Sweden. For counties where the coordinator did not respond, clinics in the respective counties were identified via a web search and contacted directly. A total of 228 e-mail addresses were collected. In November 2012, an e-mail was sent out to the clinic directors. The e-mail contained information about the purpose of the study and a link to an online survey. The clinic directors were informed about the approximate survey duration (5 min) and were ensured of anonymity. Up to two reminder e-mails were sent if the director did not complete the survey within approximately 2 weeks; reminders were not sent when the director explicitly declined participation. Towards the end of the survey, the clinic directors were asked if they were willing to forward a second online survey to all staff with patient contact at the clinic. Those who indicated willingness to do so were also asked to note the number of staff members they intended to forward the survey to, along with these individuals’ respective professions (e.g., 5 physicians, 3 psychologists, 2 nurses, etc.). Directors willing to forward the survey were then sent an e-mail with a link to the second survey, to be forwarded to all staff members. As for the first survey, the e-mail included information on study purpose, approximate survey duration (10 min), and assurance of participant anonymity. Two reminder e-mails were sent to the directors who had agreed to distribute the e-mail, requesting them to boost staff participation in the study. Given the timing of the survey before the introduction of the DSM-5, DSM-IV terms are used throughout this article.
Both surveys were constructed by the research team and disseminated via SurveyXact, a web survey tool . The clinic director survey consisted of 18 questions covering director and clinic characteristics, clinic guidelines for screening and BI, and possible alternatives for improving clinic practice in relation to identifying and addressing substance use among patients (see Additional file 1). Clinic directors also responded to additional questions regarding practice with these patients. This survey ended with space for optional free text comments on the issue of substance use among patients at the clinic. The staff survey consisted of 38 questions covering staff characteristics, use of screening and BI and possible alternatives for improving clinic practice in relation to identifying and addressing substance use among patients (see Additional file 2). At the end of both surveys, directors and staff were provided three non-mutually exclusive alternatives concerning future improvements: (1) more substance abuse training to staff; (2) improved contact with addiction clinics; and (3) more informational material to patients about substance abuse.
Data from both surveys are presented as simple frequencies. The Chi square test was used to compare directors who agreed to distribute the survey to their staff with directors who did not distribute the survey. We also conducted two secondary analyses on associations between two variables and the use of screening and BI among staff. First, as we considered it reasonable to assume that substance abuse training would be associated with use of screening and BI [34, 35], we used the question regarding experience of substance abuse training (yes/no) as a first variable. Secondly, since prevalence of substance abuse/dependence has been shown to differ markedly depending on psychiatric diagnosis , we also used type of clinic as a variable (general/psychosis/specialist). In these secondary analyses, the Chi square test was used. All statistical tests were two-sided with a significance level of 5%, and performed using IBM SPSS Statistics for MacOS X, Version 24 (IBM Corp, Armonk, NY, USA).
Of the 228 clinic directors who were sent the survey, 57.9% (n = 132) chose to participate. Of these, 46.9% (n = 62) agreed to distribute the staff survey. A comparison between directors who distributed the survey and those who did not showed no significant differences in background characteristics, with the exception of type of clinic; clinic directors at psychosis clinics were more likely to distribute the survey to their staff (77.8%) than clinic directors at specialist clinics (53.1%) and clinic directors at general clinics (43.4%; χ2 = 6.966, df 2; p = 0.031). Of the 1230 staff members estimated to have been forwarded the online link to the staff survey, 42.4% (n = 522) participated. Table 1 shows clinic director and staff characteristics.
Staff were asked to provide information on their clinical profession and length of experience in psychiatry; 32.1% (n = 166/517) were nurses, 20.3% (n = 105/517) were psychologists, 17.4% (n = 90/517) were mental health workers, 9.7% (n = 50/517) were psychiatrists, 7.2% (n = 37/517) were occupational therapists and 2.1% (n = 11/517) were physiotherapists. Concerning experience, 61.7% (n = 319/517) had more than 10 years of experience working in psychiatry, 16.4% (n = 85/517) had between 6 and 10 years’ experience and 21.9% (n = 113/517) had less than 5 years’ experience.
Use of screening and brief intervention
Among the clinic directors, 93.1% (n = 121/130) reported having guidelines for clinicians to screen for alcohol use during the initial assessment phase; 78.9% (n = 101/128) reported having such guidelines for illicit substance use (see Table 2). Further, 50.0% (n = 64) reported having guidelines stipulating that staff should provide BI when identifying hazardous alcohol use, while guidelines for providing BI when identifying patients with alcohol abuse/dependence were reported by 35.9% (n = 46). The corresponding figures for illicit substance use were 41.7% (n = 53) for hazardous use and 31.0% (n = 39) for abuse/dependence.
Among staff members, 76.4% (n = 391/512) performed clinical assessment as part of their everyday routines at the clinic; 66.6% (n = 259) of these reported routinely screening for alcohol use during assessment and the corresponding figure for illicit substance use was 57.8% (n = 199). A questionnaire or structured interview was used by 67.9% (n = 258/380) when screening for alcohol use, and by 56.4% (n = 190/337) when screening for illicit substance use. The questionnaire most frequently used when screening for alcohol use was the AUDIT (95.3%; n = 245) [14, 36] and for illicit substance use it was the DUDIT (94.2%; n = 179) . Furthermore, 36.7% (n = 177) reported that they used BI when hazardous alcohol use was identified and 33.8% (n = 162) reported using BI when abuse/dependence was identified; corresponding figures for illicit substance use were 35.7% (n = 158) for hazardous use and 32.7% (n = 145) for abuse/dependence.
Associations between substance abuse training and screening/brief intervention
Staff members who reported having received professional substance abuse training were significantly more likely to screen for alcohol use, but substance abuse training was not associated with increased likelihood of screening for illicit substance use (see Table 3). Nonetheless, staff members with substance abuse training were significantly more likely to provide BI following identification of patients with hazardous and abuse/dependence of both alcohol and illicit substances.
Associations between clinic type and screening/brief intervention
Staff members at psychosis clinics were significantly less likely to screen for both alcohol use and illicit substance use (40.3% and 32.8% respectively) compared to staff at general (73.4% vs 62.0%) and specialist clinics (72.2% vs 68.0%). However, use of BI did not significantly differ between types of clinics. See Table 4.
Suggested improvements for clinical practice
Among clinic directors, 69.0% (n = 87/126) recommended provision of substance abuse training to staff, 49.2% (n = 62/126) recommended improved contact with addiction centers and 41.3% (n = 52/126) recommended providing patients with informational material about substance abuse/dependence. Further, 48.4% (n = 61/126) stated that the clinic presently had specially designated staff with specific knowledge about alcohol and illicit substances, and 70.6% (n = 89/126) stated that the clinic currently had a local agreement regarding collaboration with a specialized addiction clinic. Among staff members, 82.5% (n = 359/435) recommended provision of substance abuse training to staff, 60.9% (n = 265/435) recommended improved contact with addiction centers and 47.1% (n = 205/435) recommended providing patients with informational material about substance abuse.
The main purpose of this study was to assess the existence of guidelines for screening and BI for substance use (alcohol and illicit substances) at psychiatric outpatient clinics in Sweden, as well as actual use of screening and BI among staff at these clinics. Almost all clinic directors who responded to the survey indicated that they had clear guidelines for staff to screen for alcohol use and illicit substance use during initial assessment, suggesting high level of awareness in psychiatric clinics about the importance of identifying substance abuse and dependence. However, only about two-thirds of staff members stated that they routinely screened for alcohol during initial assessment, and even fewer stated that they routinely screened for illicit substances. Furthermore, about half of responding clinic directors indicated that they had guidelines for offering BI, while about one-third of staff members indicated that they actually used BI regularly, suggesting that BI is not an integrated part of psychiatric treatment in Sweden.
There are several limitations to this study, most of them related to selection bias. First, with an attrition rate of about 40% among the clinic directors approached, those responding to the survey may have differed in some unknown way from those who did not respond. For example, those clinic directors who chose to respond to the survey may have had more experience of, or knowledge about, substance use and its relevance in a psychiatric context. Those who chose not to respond may have been those who knew that their clinic lacked guidelines. Secondly, only about half of clinic directors responding were willing to distribute the survey to their staff, a factor that may have introduced selection bias in the subsequent staff survey. Directors at psychosis clinics were more willing to distribute the survey, but no other differences were identified when comparing directors who agreed to distribute the survey to their staff, with those who did not. Accordingly, these two groups could have differed in some other way that was not measured. For example, those who chose to distribute the survey may have had more knowledge or experience of working with substance use issues. Also, the clinic directors who chose to distribute the survey could hypothetically have selectively distributed the survey only to a certain subsection of their staff, for example to those at the clinic whom they knew worked with or were more familiar with substance use. Thirdly, almost 60% of staff members who were estimated to have been sent the survey did not respond. We do not know to what extent staff members who responded to the survey were representative of the staff population at large. It could be that staff members who considered substance use an important issue were the ones who took the time to answer the survey, they may have had more experience in working with these issues, or they may have had more substance abuse training. A final limitation relates to the anonymous nature of the staff survey; since we did not ask staff members to indicate where they worked, we have no information about which specific clinics they were working at. There may have been some clinics where no staff responded and other clinics where all or most staff members responded.
Constructive management of patients with substance use in psychiatric outpatient clinics is a complicated matter, involving decision-making at the clinic level as well as policy decisions in the form of national guidelines over which the individual clinic has no influence. Nevertheless, awareness of a patient’s substance use habits is unquestionably a crucial component of psychiatric treatment, and psychiatric clinics should have a well thought-out plan in place on how to identify and manage patients’ substance use. The clinical research literature consistently suggests that treatment of patients with both a psychiatric disorder and substance abuse/dependence optimally should focus on both disorders, rather than on focusing on just one or the other . Although psychotherapy programs have, with some success, been developed specifically to satisfy this aim [38, 39], integrated treatment is often difficult to offer under real-life conditions given the fact that psychiatry and addiction clinics usually are managed by separate health care entities. Nonetheless, about half of the clinic directors in our survey indicated that they maintained local collaboration with addiction care services.
Use of BI was quite rare in our sample, a finding which perhaps is not surprising. Although BI has been shown to be a safe and effective intervention for alcohol when used in other parts of health care, particularly in primary care , its place in psychiatry is still unclear and more trials are needed before any conclusions on efficacy in this population can be drawn. Further, the use of BI for illicit substance use is even less investigated. Thus, research is still lacking as to whether BI is even feasible or safe in a psychiatric population. Further, our finding that increased substance abuse training was the most common recommendation for clinical improvement by both clinic directors and staff suggests that the lack of substance abuse training among staff was perceived as a real problem by both groups. Offering staff substance abuse training could thus potentially be an effective way of increasing adherence to guidelines , as relatively brief training sessions have been found to improve staff members’ self-perceived knowledge and attitudes towards working with this issue [34, 42]. Lastly, given the consistently high rates of comorbidity reported among patients with schizophrenia, with up to 50% of patients at some point in their life suffering from substance abuse or dependence , and considering the fact that premature mortality among these patients due to medical conditions attributable to substance use is common , the apparent low use of screening among staff in psychosis clinics was surprising and seems to suggest a very real problem that needs to be addressed.
Almost all clinic directors stated that they had clear guidelines for staff to screen for alcohol use and illicit substance use, but use of screening among staff was markedly lower than would be expected. Our results thus suggest a gap between the guidelines that the clinic directors report and actual adherence to guidelines by staff. Substance abuse training among staff is rare and may be a contributing factor to low adherence since those indicating that they had substance abuse training reported performing screening and brief intervention to a greater degree. Provision of substance abuse training to staff in psychiatry might thus be a key factor needed to improve frequency of screening and brief intervention. Clinics specializing in psychosis might need to consider making extra efforts to improve screening practices.
substance use disorders
alcohol use disorders
Alcohol Use Disorders Identification Test
Drug Use Disorders Identification Test
National Institute for Health and Care Excellence
National Institute on Alcohol Abuse and Alcoholism
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama. 1990;264(19):2511–8.
Lai HM, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1–13.
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807–16.
Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res. 2004;67(2–3):157–66.
Hunt GE, Malhi GS, Cleary M, Lai HM, Sitharthan T. Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990–2015: systematic review and meta-analysis. J Affect Disord. 2016;206:331–49.
Lynskey MT. The comorbidity of alcohol dependence and affective disorders: treatment implications. Drug Alcohol Depend. 1998;52(3):201–9.
Toftdahl NG, Nordentoft M, Hjorthoj C. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):129–40.
Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry. 2004;56(10):730–7.
Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 2005;118(4):330–41.
Castaneda R, Sussman N, Westreich L, Levy R, O’Malley M. A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders. J Clin Psychiatry. 1996;57(5):207–12.
Worthington J, Fava M, Agustin C, Alpert J, Nierenberg AA, Pava JA, et al. Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. Psychosomatics. 1996;37(6):518–22.
Linnoila MI. Benzodiazepines and alcohol. J Psychiatr Res. 1990;24(Suppl 2):121–7.
Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD. The role of hazardous drinking reductions in predicting depression and anxiety symptom improvement among psychiatry patients: a longitudinal study. J Affect Disord. 2016;206:169–73.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction. 1993;88:791–804.
Alcohol-use disorders: prevention. PH24. National Institue for Health and Care Excellence PH24. https://www.nice.org.uk/guidance/ph24/chapter/1-recommendations. Accessed 10 Mar 2017.
Helping patients who drink too much: a clinician’s guide. National Institute on Alcohol Abuse and Alcoholism. https://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/clinicians_guide.htm. Accessed 11 Mar 2017.
Nationella riktlinjer för sjukdomsförebyggande metoder. Tobaksbruk, riskbruk av alkohol, otillräcklig fysisk aktivitet och ohälsosamma matvanor. Stöd för styrning och ledning [National Guidelines for NCD prevention. Tobacco use, risky use of alcohol, insufficient physical activity and unthealthy diet. Support for management and leadership]. Socialstyrelsen. https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18484/2011-11-11.pdf. Accessed 11 Mar 2017
Kaner EF, Beyer FR, Muirhead C, Campbell F, Pienaar ED, Bertholet N, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2018;2:Cd004148.
Schmidt CS, Schulte B, Seo HN, Kuhn S, O’Donnell A, Kriston L, et al. Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings. Addiction (Abingdon Engl). 2016;111(5):783–94.
Nehlin C, Gronbladh L, Fredriksson A, Jansson L. Brief alcohol intervention in a psychiatric outpatient setting: a randomized controlled study. Addict Sci Clin Pract. 2012;7:23.
Satre DD, Leibowitz A, Sterling SA, Lu Y, Travis A, Weisner C. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol. 2016;84(7):571–9.
Hulse GK, Tait RJ. Five-year outcomes of a brief alcohol intervention for adult in-patients with psychiatric disorders. Addiction (Abingdon Engl). 2003;98(8):1061–8.
Eberhard S, Nordstrom G, Hoglund P, Ojehagen A. Secondary prevention of hazardous alcohol consumption in psychiatric out-patients: a randomised controlled study. Soc Psychiatry Psychiatr Epidemiol. 2009;44(12):1013–21.
National Guidelines for Care and Support for Abuse and Dependence. Indicators and a situational report for 2017. https://www.socialstyrelsen.se/SiteCollectionDocuments/2017-12-23-indikatorbilaga.pdf. Accessed 9 Jan 2018.
Hildebrand M. The psychometric properties of the Drug Use Disorders Identification Test (DUDIT): a review of recent research. J Subst Abuse Treat. 2015;53:52–9.
Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11:22–31.
Nationella Riktlinjer för Vård och Stöd vid Missbruk och Beroende – Stöd för styrning och ledning. (National Guidelines for Health Care and Support for Abuse and Dependence). Stockholm: Socialstyrelsen. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19770/2015-4-2.pdf. Accessed 10 Mar 2017.
Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings CG120. National Institue for Health and Care Excellence; CG120. https://www.nice.org.uk/guidance/CG120/chapter/1-Guidance#recognition-of-psychosis-with-coexisting-substance-misuse. Accessed 13 Mar 2017.
Padwa H, Urada D, Gauthier P, Rieckmann T, Hurley B, Crevecouer-MacPhail D, et al. Organizing publicly funded substance use disorder treatment in the United States: moving toward a service system approach. J Subst Abuse Treat. 2016;69:9–18.
Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction (Abingdon Engl). 2012;107(5):957–66.
Saitz R, Palfai TP, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travaglini CA, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–13.
Boumparis N, Karyotaki E, Schaub MP, Cuijpers P, Riper H. Internet interventions for adult illicit substance users: a meta-analysis. Addiction (Abingdon Engl). 2017;112(9):1521–32.
Survey Xact. www.surveyxact.se. Accessed 30 June 2018.
Hunter SB, Watkins KE, Wenzel S, Gilmore J, Sheehe J, Griffin B. Training substance abuse treatment staff to care for co-occurring disorders. J Subst Abuse Treat. 2005;28(3):239–45.
Skinner N, Roche AM, Freeman T, McKinnon A. Health professionals’ attitudes towards AOD-related work: Moving the traditional focus from education and training to organizational culture. Drugs Educ Prev Policy. 2009;16(3):232–49.
Bergman H, Källmén H. Alcohol use among Swedes and a psychometric evaluation of the Alcohol Use Disorders Identification Test. Alcohol Alcohol. 2002;37:245–51.
Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J. 2004;27(4):360–74.
Baker AL, Thornton LK, Hiles S, Hides L, Lubman DI. Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review. J Affect Disord. 2012;139(3):217–29.
Baker AL, Hiles SA, Thornton LK, Hides L, Lubman DI. A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatr Scand. 2012;126(4):243–55.
Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;2:Cd400148.
Satre DD, Leibowitz AS, Mertens JR, Weisner C. Advising depression patients to reduce alcohol and drug use: factors associated with provider intervention in outpatient psychiatry. Am J Addict. 2014;23(6):570–5.
Nehlin C, Fredriksson A, Gronbladh L, Jansson L. Three hours of training improve psychiatric staff’s self-perceived knowledge and attitudes toward problem-drinking patients. Drug Alcohol Rev. 2012;31(4):544–9.
Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Knowles JA, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71(3):248–54.
AHB, CS and KS conceived the study design and created the surveys. CS and PG performed all quantitative analyses. EP performed a qualitative analysis of respondent comments (not shown) and contributed to the manuscript with critical comments. All authors read and approved the final manuscript.
We would like to thank the clinical directors and staff for their responses to the survey. We also thank Sara Ullman, BSW, for her contribution to the survey design and recruitment process.
Author AHB is the author of two Swedish-language manuals pertaining to use and scoring of the AUDIT, DUDIT and the Alcohol-E and DUDIT-E screening tests, respectively. The other authors declare that they have no competing interests.
Availability of data and materials
The datasets generated and/or analysed during the current study are available in the Open ICPSR repository, Persistent URL: http://doi.org/10.3886/E100534V1.
Consent for publication
Ethics approval and consent to participate
All participants were informed about the aim of the study and procedure for data collection. This information included a standard formulation regarding the voluntary nature of study participation as well as the message that participants could leave the study at any time without any negative consequences. A consultative statement from the Stockholm Regional Ethical Review Board was given (2012/1695-31/5) stating that no ethical approval was deemed to be needed as information collected was not considered sensitive.
This study was supported by grants to author AHB from the Swedish Research Council, nr K2012-61X-22132-01-6, supporting authors CS, KS and EP during manuscript preparation; and grant nr K2012-61P-22131-01-6, supporting author AHB’s salary throughout the project. Author PG contributed as an unpaid student intern during the initial phase of data analysis. The funding organization had no role in the conception of the study, in the analyses of the data, in the writing of the manuscript, nor in the decision to submit it for publication.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.